Astera Labs (NASDAQ:ALAB) Trading 2.7% Higher – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALABGet Free Report)’s share price traded up 2.7% during trading on Wednesday . The stock traded as high as $290.63 and last traded at $290.30. 1,872,102 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 5,399,010 shares. The stock had previously closed at $282.65.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. increased their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Stifel Nicolaus upped their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research note on Monday, August 17th. Finally, Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $333.00.

Read Our Latest Report on ALAB

Astera Labs Price Performance

The firm has a fifty day moving average of $348.88 and a two-hundred day moving average of $247.38. The stock has a market capitalization of $50.36 billion, a P/E ratio of 143.71 and a beta of 3.84.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the firm earned $0.44 earnings per share. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the transaction, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently bought and sold shares of ALAB. California State Teachers Retirement System raised its position in shares of Astera Labs by 49,273.2% in the 2nd quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock worth $48,378,580,000 after acquiring an additional 99,955,684 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Astera Labs during the 2nd quarter worth $6,609,581,000. Bank of America Corp DE bought a new stake in Astera Labs during the second quarter valued at about $1,061,791,000. Atreides Management LP boosted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Finally, Amundi grew its stake in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.